The combinatorial detection of glycoprotein epitopes (CD15, CD24, CD44, CD57, TrkA) and the chemokine receptor CXCR4 (CD184) uncovers NB cellular heterogeneity. This evidence concerns the gene CD24 and neuroblastoma.